Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Frontline Gastroenterology|August 2, 2013
Measurement of faecal calprotectin and lactoferrin in inflammatory bowel diseaseC A Lamb, J C MansfieldFrontline Gastroenterology|February 28, 2018
Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini reviewT S Chew, J C MansfieldAlimentary Pharmacology & Therapeutics|July 27, 2001
Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatmentG P Aithal, J C MansfieldAlimentary Pharmacology & Therapeutics|April 9, 2005
Review article: smoking cessation as primary therapy to modify the course of Crohn's diseaseG J Johnson, J Cosnes, J C MansfieldOsteoarthritis and Cartilage|June 9, 2015
The micromechanics of the superficial zone of articular cartilageJ C Mansfield, J S Bell, C P WinlovePostgraduate Medical Journal|April 17, 2003
Management of irritable bowel syndromeM C Gunn, A A Cavin, J C MansfieldGut|January 1, 1995
Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's diseaseJ C Mansfield, M H Giaffer, C D HoldsworthJournal of the Royal College of Physicians of London|March 1, 1997
Information for patients about inflammatory bowel diseaseJ C Mansfield, A R Tanner, M G BrambleGut|May 1, 1997
A prospective evaluation of cytology from biliary stricturesJ C Mansfield, S M Griffin, V Wadehra, et al.Genes and Immunity|June 8, 2001
The CC chemokine receptor 5 delta32 mutation is not associated with inflammatory bowel disease (IBD) in NE EnglandA Craggs, M Welfare, P T Donaldson, et al.Pageof 3